Differential response of hepatocellular carcinoma glycolytic metabolism and oxidative stress markers after exposure to human amniotic membrane proteins

• Published in: Molecular biology reports 2022-08, Vol.49 (8), p.7731-7741
• Main Authors: Alves, Andreia P, Rocha, Sandra M, Mamede, Ana C, Braga, Patrícia C, Alves, Marco G, Oliveira, Pedro F, Botelho, Filomena M, Maia, Cláudio J
• Format: Article
• Language: English
• Subjects: Amniotic membrane; Animal Anatomy; Animal Biochemistry; Antioxidants; Biomedical and Life Sciences; Carcinogenesis; Cell culture; Culture media; Extracellular matrix; Glucose; Glucose metabolism; Glycolysis; Hepatocellular carcinoma; Histology; L-Lactate dehydrogenase; Lactic acid; Life Sciences; Liver cancer; Membrane proteins; Metabolism; Morphology; Nitration; Original Article; Oxidative metabolism; Oxidative stress; Proteins; Tumor cell lines
• ISSN: 0301-4851; 1573-4978
• DOI: 10.1007/s11033-022-07598-5

Background The human Amniotic Membrane (hAM) has been studied as a potential therapeutic option in cancer, namely in hepatocellular carcinoma. Previously, our research group evaluated the effect of human Amniotic Membrane Protein Extracts (hAMPE) in cancer therapy, demonstrating that hAMPE inhibit the metabolic activity of human hepatocellular carcinoma cell lines: Hep3B2.1-7, HepG2 and Huh7. Therefore, and considering the close relationship between metabolic activity and oxidative stress, the aim of this study was to evaluate the effect of hAMPE treatment in glucose metabolism and its role in oxidative stress of hepatocellular carcinoma. Methods and Results Glucose uptake and lactate production was assessed by 1 H-NMR, and the expression of several mediators of the glycolytic pathway was evaluated by Western blot or fluorescence. Total antioxidant capacity (TAC) and biomarkers of oxidative stress effects in proteins were detected. Our results showed that hAMPE treatment increased glucose consumption on Hep3B2.1-7, HepG2, and Huh7 through the increase of GLUT1 in Hep3B2.1-7 and Huh7, and GLUT3 in HepG2 cells. It was observed an increased expression of 6-phosphofrutokinase (PFK-1L) in all cell lines though glucose was not converted to lactate on HepG2 and Huh7 cells, suggesting that hAMPE treatment may counteract the Warburg effect observed in carcinogenesis. In Hep3B2.1-7, hAMPE treatment induced an increase in expression of lactate dehydrogenase (LDH) and monocarboxylate transporter isoform 4 (MCT4). We further detected that hAMPE enhances the TAC of culture media after 2 and 8 h. This was followed by a degree of protection against proteins nitration and carbonylation. Conclusions Overall, this work highlights the potential usefulness of hAMPE as anticancer therapy through the modulation of the glycolytic and oxidative profile in human hepatocellular carcinoma.